Emerging AI Opportunities in Pharmaceuticals and Healthcare with Eli Lilly CIDO Diogo Rau, AstraZeneca CDO & CIO Cindy Hoots, and Bristol Myers Squibb CDTO Greg Meyers
880: Few industries are as knowledge-centric as pharma and healthcare, where groundbreaking innovations can positively impact lives and potentially eradicate diseases. In this episode of Technovation, we feature a discussion from our May 2024 Metis Strategy Digital Symposium, where AstraZeneca CDO/CIO Cindy Hoots, Bristol Myers Squibb CDTO Greg Meyers, and Eli Lilly CIDO Diogo Rau explore the profound impact of artificial intelligence on talent management, research and development, and operational efficiencies within the pharma industry. These executives delve into the innovative applications of AI, from improving clinical trials and document generation to enhancing internal workflows and customer service. Discover how these AI pioneers are laying the foundation for a future where AI and human ingenuity drive unprecedented advancements in medicine and patient care.
Emerging AI Opportunities in Pharmaceuticals and Healthcare with Eli Lilly CIDO Diogo Rau, AstraZeneca CDO & CIO Cindy Hoots, and Bristol Myers Squibb CDTO Greg Meyers | Technovation with Peter High (CIO, CTO, CDO, CXO Interviews) podcast - Listen or read transcript on Metacast
